ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age
Topic Area [clear]
Experience
Course Format [clear]
SIG
Instructional Level
Results 21 - 30 of 86
Presenter(s): Emily R. Doll, MA, MS, CCC-SLP
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This session explores effective techniques and resources to help children with selective mutism (SM), an anxiety-based disorder that significantly impacts a child's ability to speak in certain contexts, make progress in school and beyond. The speaker reviews myths and facts about SM and explores the SLP's role in working with children with this disorder. The session includes assessment tips, evidence-based treatment strategies, and ways to support carryover of skills to other contexts and with caregivers and school staff.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Rebecca J Boersma, MA, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session reviews the emerging evidence of neurological manifestations of COVID-19 and identifies how SLPs can use their unique position to maximize patient outcomes-whether as a member of an interdisciplinary team or as a solo provider. The session strives to increase clinicians' confidence in their abilities to: identify common cognitive-communication symptoms for patients who have recovered from COVID-19, and evaluate and treat with an individualized, patient-centered approach.
Presenter(s): Margaret Kenna; Amanda M Griffin; Charlotte Morse-Fortier; Kelly N Jahn; David Faller; Julie Gayle Arenberg; Michael A Cohen; Elizabeth DesRoche
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is evidence that many factors contribute to the varied performance outcomes among pediatric cochlear implant (CI) recipients, including etiology and quality of the electrode neuron interfaces (ENI). This course examines a study that investigated the intersection of these factors by analyzing the records and device settings for 156 children with confirmed diagnoses of either enlarged vestibular aqueduct (EVA) or Connexin-26 mutations.
Presenter(s): Georgia Cambridge; Tracey Taylor; Wayne Wilson; Wendy Arnott
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a systematic review that aimed to answer the PICO-format clinical research question: For adults with cochlear implants and severe to profound postlingual sensorineural hearing loss, is auditory training effective in improving listening outcomes?
Credit(s): PDHs: 6.0, ASHA CEUs*: 0.6
Summary: Concussion - or mild traumatic brain injury (mTBI) - is a unique injury that is different from more severe brain injury, and addressing the associated cognitive deficits requires personalized, targeted interventions These articles discuss research and practical implications for the management of cognitive symptoms of mTBI, including defining the role of the SLP on interdisciplinary management teams, exploring specific assessment and treatment strategies, and emphasizing functional, personalized goals. The articles are from a 2021 American Journal of Speech-Language Pathology forum "Interdisciplinary Management of Concussion or Mild TBI." The articles provide evidence and strategies to increase clinician confidence and effectiveness when working with individuals with concussion or mTBI.
Credit(s): PDHs: 5.0, ASHA CEUs*: 0.5
Summary: This journal self-study includes select papers on conversation and discourse production that were presented at the 49th Clinical Aphasiology Conference (2019) in Whitefish, Montana. The articles reflect the current state of research on treatments to improve conversation and discourse production for people with aphasia.
Presenter(s): Jennifer P. Lundine, PhD, CCC-SLP, BC-ANCDS
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This session—a recorded session from ASHA’s 2020 Health Care Connect online conference—explores the incidence and common mechanisms of brain injury in children and adolescents and the potential effects of these injuries to cognition and communication. Using case studies, the speaker discusses methods to improve long-term outcomes for these youth through initial assessment and transition planning. This session is designed to accompany the 2020 Schools Connect online conference session Assessments and Interventions in the Schools for Youth With Brain Injury. Together, the two sessions address provision of services for the same students across medical and school settings.
Presenter(s): Debbie Stanhouse, MEd, CCC-SLP, CCM
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session—a recorded session from ASHA’s 2020 Schools Connect conference—focuses on the continued rehabilitation of students with brain injuries through the art of successful transition into the school setting. The speaker addresses how accurate assessment leads to the establishment and implementation of successful intervention plans that include educationally relevant goals. This session is designed to accompany the 2020 Health Care Connect online conference session Initial Assessment and Transition Planning for Youth With Brain Injury. Together, the two sessions address provision of services for the same students across medical and school settings.
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This journal self-study course highlights the impacts of the COVID-19 pandemic on people with aphasia, patients with cognitive communication impairments, and patient-provider communication. The findings can inform decision-making and assist SLPs in optimizing treatment for communication challenges for patients with COVID-19 as well as those for whom treatment has been altered as a result of the pandemic.
<< 1 2 3 4 5 6 7 8 9 >>